Business Description
DNA Group (TR) Ltd
ISIN : IL0011038523
Compare
Compare
Traded in other countries / regions
DNA.Israel IPO Date
2007-05-31Description
DNA Group (TR) Ltd invests in biomed companies and has also started to engage in profitable real estate in England.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.98 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 44.04 | |||||
| Beneish M-Score | 5.11 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 29.8 | |||||
| 3-Year FCF Growth Rate | 33.1 | |||||
| 3-Year Book Growth Rate | 35.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 36.46 | |||||
| 9-Day RSI | 47.32 | |||||
| 14-Day RSI | 51.43 | |||||
| 6-1 Month Momentum % | 9.73 | |||||
| 12-1 Month Momentum % | -1.16 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 97.73 | |||||
| Quick Ratio | 97.73 | |||||
| Cash Ratio | 97.37 | |||||
| Days Sales Outstanding | 305.36 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -58.7 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -710.46 | |||||
| Net Margin % | -384.64 | |||||
| FCF Margin % | -221.57 | |||||
| ROE % | -1.46 | |||||
| ROA % | -1.43 | |||||
| ROIC % | -13.62 | |||||
| ROCE % | -2.66 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio without NRI | 171.6 | |||||
| PEG Ratio | 3.09 | |||||
| PS Ratio | 429 | |||||
| PB Ratio | 1.33 | |||||
| Price-to-Tangible-Book | 1.34 | |||||
| EV-to-EBIT | -17.93 | |||||
| EV-to-EBITDA | -17.93 | |||||
| EV-to-Revenue | 127.38 | |||||
| EV-to-FCF | -57.49 | |||||
| Price-to-Projected-FCF | 2.38 | |||||
| Price-to-Peter-Lynch-Fair-Value | 17.16 | |||||
| Price-to-Graham-Number | 3.18 | |||||
| Price-to-Net-Current-Asset-Value | 1.62 | |||||
| Price-to-Net-Cash | 1.62 | |||||
| Earnings Yield (Greenblatt) % | -5.58 | |||||
| FCF Yield % | -0.64 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
DNA Group (TR) Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₪) | 0.306 | ||
| EPS (TTM) (₪) | -0.01 | ||
| Beta | 0 | ||
| Volatility % | 57.81 | ||
| 14-Day RSI | 51.43 | ||
| 14-Day ATR (₪) | 0.054875 | ||
| 20-Day SMA (₪) | 0.8524 | ||
| 12-1 Month Momentum % | -1.16 | ||
| 52-Week Range (₪) | 0.56 - 1.1 | ||
| Shares Outstanding (Mil) | 123.16 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
DNA Group (TR) Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
DNA Group (TR) Ltd Stock Events
| Event | Date | Price(₪) | ||
|---|---|---|---|---|
| No Event Data | ||||
DNA Group (TR) Ltd Frequently Asked Questions
What is DNA Group (TR) Ltd(XTAE:DNA)'s stock price today?
The current price of XTAE:DNA is ₪0.86. The 52 week high of XTAE:DNA is ₪1.10 and 52 week low is ₪0.56.
When is next earnings date of DNA Group (TR) Ltd(XTAE:DNA)?
The next earnings date of DNA Group (TR) Ltd(XTAE:DNA) is .
Does DNA Group (TR) Ltd(XTAE:DNA) pay dividends? If so, how much?
DNA Group (TR) Ltd(XTAE:DNA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers